Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.

Friedland BA, Gundacker H, Achilles SL, Chen BA, Hoesley C, Richardson BA, Kelly CW, Piper J, Johnson S, Devlin B, Steytler J, Kleinbeck K, Dangi B, Friend C, Song M, Mensch B, van der Straten A, Jacobson C, Hendrix CW, Brown J, Blithe D, Hiller SL, MTN-030/IPM 041 and MTN-044/IPM 053/CCN019 Protocol Teams for the Microbicide Trials Network and the Contraceptive Clinical Trials Network

Open source

DOI: 10.1371/journal.pone.0312957
Published: 2025
Container: PloS one
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0312957,
  title = {Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.},
  author = {Friedland BA and Gundacker H and Achilles SL and Chen BA and Hoesley C and Richardson BA and Kelly CW and Piper J and Johnson S and Devlin B and Steytler J and Kleinbeck K and Dangi B and Friend C and Song M and Mensch B and van der Straten A and Jacobson C and Hendrix CW and Brown J and Blithe D and Hiller SL and MTN-030/IPM 041 and MTN-044/IPM 053/CCN019 Protocol Teams for the Microbicide Trials Network and the Contraceptive Clinical Trials Network},
  year = {2025},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0312957},
  url = {https://doi.org/10.1371/journal.pone.0312957}
}

RIS

TY  - JOUR
TI  - Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.
AU  - Friedland BA
AU  - Gundacker H
AU  - Achilles SL
AU  - Chen BA
AU  - Hoesley C
AU  - Richardson BA
AU  - Kelly CW
AU  - Piper J
AU  - Johnson S
AU  - Devlin B
AU  - Steytler J
AU  - Kleinbeck K
AU  - Dangi B
AU  - Friend C
AU  - Song M
AU  - Mensch B
AU  - van der Straten A
AU  - Jacobson C
AU  - Hendrix CW
AU  - Brown J
AU  - Blithe D
AU  - Hiller SL
AU  - MTN-030/IPM 041 and MTN-044/IPM 053/CCN019 Protocol Teams for the Microbicide Trials Network and the Contraceptive Clinical Trials Network
PY  - 2025
JO  - PloS one
DO  - 10.1371/journal.pone.0312957
UR  - https://doi.org/10.1371/journal.pone.0312957
ER  -

APA

BA, F., H, G., SL, A., BA, C., C, H., BA, R., CW, K., J, P., S, J., B, D., J, S., K, K., B, D., C, F., M, S., B, M., A, V. D. S., C, J., CW, H., J, B., D, B., SL, H., & Network, M. 0. A. M. 0. P. T. F. T. M. T. N. A. T. C. C. T. (2025). Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.. PloS one. https://doi.org/10.1371/journal.pone.0312957

Source records

pubmed · retrieved 2026-09-25T22:42:43.053Z